Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | CCNT1 | O60563 | 5/20 | 0.44 |
| ▸ | CDK9 | P50750 | 5/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.38 |
| ▸ | MGLL | Q99685 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | ACP3 | P15309 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3390402 | 0.94 | CCNT1 (0.46) | CCNT1CDK9HDAC1TSHRMAPT | |
| SCHEMBL3922951 | 0.86 | CCNT1 (0.42) | CCNT1CDK9HDAC1TSHRMAPT | |
| SCHEMBL9502876 | 0.86 | CCNT1 (0.42) | CCNT1CDK9HDAC1TSHRMAPT | |
| SCHEMBL29427115 | 0.84 | IDO1 (0.44) | CCNT1CDK9HDAC1MAPTHTT | |
| SCHEMBL1831290 | 0.84 | IDO1 (0.44) | CCNT1CDK9HDAC1MAPTHTT | |
| SCHEMBL9445966 | 0.83 | TAAR1 (0.46) | CCNT1CDK9HDAC1 | |
| SCHEMBL914611 | 0.83 | XIAP (0.41) | CCNT1CDK9HDAC1 | |
| SCHEMBL1307260 | 0.83 | IDO1 (0.43) | CCNT1CDK9HDAC1NPSR1 | |
| SCHEMBL478915 | 0.83 | CCNT1 (0.56) | CCNT1CDK9HDAC1NPY5R | |
| SCHEMBL1759923 | 0.83 | IDO1 (0.43) | CCNT1CDK9HDAC1TSHRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007005172-A1 | METHOD FOR THE PREPARATION OF ARALKYL DIALKYL PHOSPHONATES | FERRO CORPORATION (US) | 2007-01-11 | — | — | WO | disclosed |
| US-20070004833-A1 | METHOD FOR THE PREPARATION OF ARALKYL DIALKYL PHOSPHONATES | FERRO CORPORATION (US) | 2007-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070004833-A1 | METHOD FOR THE PREPARATION OF ARALKYL DIALKYL PHOSPHONATES | ADK, ARAF, RPN1 | POLB 2434/4885CCNT1 3192/4885CDK9 684/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.